FDA Reissues High Throughput COVID-19 Testing Solution for Emergency Use
The LumiraDx SARS-CoV-2 RNA STAR Complete has been authorized by FDA for emergency use under an EUA for use by authorized laboratories.
Read MorePosted by Andy Lundin | Dec 3, 2021 | Covid 19, Rapid Assays |
The LumiraDx SARS-CoV-2 RNA STAR Complete has been authorized by FDA for emergency use under an EUA for use by authorized laboratories.
Read MorePosted by Andy Lundin | Dec 2, 2021 | Covid 19, Immunoassay Reagents & test Kits |
BD published a statement clarifying the efficacy of its rapid antigen and PCR tests to monitor for the COVID-19 Omicron variant.
Read MorePosted by Andy Lundin | Dec 2, 2021 | Covid 19, Immunoassay Reagents & test Kits |
Hologic designed its assays with the expectation that SARS-CoV-2 would continue to evolve, which is the natural path for viruses.
Read MorePosted by Andy Lundin | Dec 1, 2021 | Covid 19, Immunoassay Reagents & test Kits |
This new multiplex qPCR-based test screens for the SARS-CoV-2 virus and simultaneously identifies and differentiates all the new mutating COVID-19 variants.
Read MorePosted by Chris Wolski | Nov 29, 2021 | Covid 19, Immunoassay Reagents & test Kits |
Thermo Fisher Scientific Inc. has confirmed that its PCR TaqPath COVID-19 Combo Kit, and TaqPath COVID-19 CE-IVD RT-PCR Kit can detect the Omicron variant.
Read More